VU

Velaparambil Unni Deviraj

Active Director Director DIN 11266965
DIN 11266965 First appointment Aug 2025 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Velaparambil Unni Deviraj

Data last updated:

Velaparambil Unni Deviraj is a Director at Deviraj Padma Global Private Limited (since 2025). The company operates in Healthcare.

DIN 11266965
Primary Designation Director
Industry Healthcare
First Appointment 28 Aug 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Deviraj Padma Global Private Limited U86100KL2025PTC096723
Director28 Aug 20252025Active

Board colleagues of Velaparambil Unni Deviraj

NameDINCompanyDesignation
Ganesan Padma Saroja11266964Deviraj Padma Global Private LimitedDirector

Directorship timeline

Open interactive timeline →
Deviraj Padma Global Private Limited
Premium access

Shareholding and investment profile for Velaparambil Unni Deviraj

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Velaparambil Unni Deviraj

Velaparambil Unni Deviraj currently holds 1 directorship: Deviraj Padma Global Private Limited (Director, since 28 Aug 2025).

Velaparambil Unni Deviraj was first appointed on 28 Aug 2025 as Director at Deviraj Padma Global Private Limited.

The current boards of Velaparambil Unni Deviraj's companies include Ganesan Padma Saroja (Deviraj Padma Global Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available